Skip to content
WeighLab

MediRX vs Nu Image Medical

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MediRX

Provider comparison

Patients who want injection or oral options and will confirm the recurring price and prescribed product before paying.

Semaglutide / month
From $179/moCompounded injection headline; conflicting $149 promotional listing
Tirzepatide / month
From $399/moCompounded injection headline; conflicting $199 promotional listing
Index 75/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check MediRX pricing Read review

Nu Image Medical

Provider comparison

Shoppers comfortable choosing a multi-month compounded injection or rapid-dissolve-tablet supply after a provider review.

Semaglutide / month
$89/moAs low as, 6-month supply, compounded
Tirzepatide / month
$89/moAs low as, 6-month supply, compounded
Index 74/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Nu Image Medical pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

MediRX has the higher Cost-Efficiency Index: 75/100 versus 74/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

MediRX
All 50 states + DC (services vary)
Nu Image Medical
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MediRX

Nu Image Medical

Semaglutide / month
MediRX: From $179/moCompounded injection headline; conflicting $149 promotional listing
Nu Image Medical: $89/moAs low as, 6-month supply, compounded
Tirzepatide / month
MediRX: From $399/moCompounded injection headline; conflicting $199 promotional listing
Nu Image Medical: $89/moAs low as, 6-month supply, compounded
Semaglutide / year (modeled)
MediRX: $2,148
Nu Image Medical: $1,068
Tirzepatide / year (modeled)
MediRX: $4,788
Nu Image Medical: $1,068
State availability
MediRX: All 50 states + DC (services vary)
Nu Image Medical: All 50 states
Oral / sublingual option listed
MediRX: Yes
Nu Image Medical: Yes
Brand-name access listed
MediRX: Not confirmed
Nu Image Medical: Not confirmed
Provider facts checked
MediRX: October 2026
Nu Image Medical: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

MediRX

Patients who want injection or oral options and will confirm the recurring price and prescribed product before paying.

Reasons to consider it

  • Offers compounded injections and oral-tablet options
  • Names OpenLoop as its clinician network
  • Terms list RedRock, Health Warehouse, Precision Compounding Pharmacy and Triad Rx

What to weigh up

  • Hero, promotional cards and plan tables show different figures; confirm the ongoing total
  • A brand Ozempic card has tirzepatide copy; confirm the actual drug and product
  • No individual medical director is named

Compounded drugs are not FDA-approved. Understand the medication options.

Check MediRX pricing Read the full MediRX review

Nu Image Medical

Shoppers comfortable choosing a multi-month compounded injection or rapid-dissolve-tablet supply after a provider review.

Reasons to consider it

  • Publishes the identity of all four fulfillment pharmacies in its terms (Absolute Pharmacy LLC, Belmar Pharma Solutions, The Pharmacy Hub, TMC Acquisition dba Tailor Made Compounding) rather than staying anonymous about who compounds the medication
  • LegitScript certified with a visible certificate number (453964)
  • Both injectable and rapid-dissolve-tablet (RDT) formulations available for both semaglutide and tirzepatide

What to weigh up

  • The advertised injection rate is tied to a six-month supply, not a confirmed month-to-month plan
  • Your prescribed dose and chosen supply determine the final quote
  • Prescriptions are non-refundable, with a separate limited exception for eligible WAYT-less patients

Compounded drugs are not FDA-approved. Understand the medication options.

Check Nu Image Medical pricing Read the full Nu Image Medical review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MediRXNu Image Medical
Normalized Cost/Month
MediRX:
65/100
Nu Image Medical:
74/100
Price Transparency
MediRX:
84/100
Nu Image Medical:
78/100
Nationwide Access
MediRX:
86/100
Nu Image Medical:
86/100
Formulation Options
MediRX:
77/100
Nu Image Medical:
77/100
Clinical Oversight
MediRX:
74/100
Nu Image Medical:
78/100
Contract Flexibility
MediRX:
63/100
Nu Image Medical:
43/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to MediRXAlternatives to Nu Image Medical
More provider matchups
CoreAge Rx vs MediRXCoreAge Rx vs Nu Image Medical
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.